During the past decade, Regional West Medical Center Cancer Center conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 17 clinical trials were completed, i.e. on average, 70.8% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 16 clinical trials were completed. i.e. 800% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Regional West Medical Center Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 21 trials, followed by "Alliance for Clinical Trials in Oncology" with 7 trials sponsored, "SWOG Cancer Research Network" with 7 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored and "NRG Oncology" with 3 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Regional West Medical Center Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 18 trials as a collaborator, "Canadian Cancer Trials Group" with 4 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Cancer Prevention Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Regional West Medical Center Cancer Center" are "Recurrent Melanoma" (4 trials), "Stage IIIC Cutaneous Melanoma AJCC v7" (4 trials), "Stage IV Cutaneous Melanoma AJCC v6 and v7" (4 trials), "Recurrent Squamous Cell Lung Carcinoma" (3 trials) and "Stage IIIB Cutaneous Melanoma AJCC v7" (3 trials). Many other conditions were trialed in "Regional West Medical Center Cancer Center" in a lesser frequency.

Most popular intervention types in "Regional West Medical Center Cancer Center" are "Drug" (32 trials), "Other" (29 trials), "Biological" (16 trials), "Radiation" (5 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (20 trials), "Quality-of-Life Assessment" (10 trials), "Ipilimumab" (7 trials), "Nivolumab" (6 trials) and "Cisplatin" (5 trials). Other intervention names were less common.

The vast majority of trials in "Regional West Medical Center Cancer Center" are 34 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Regional West Medical Center Cancer Center". undefined are not yet recruiting, 7 are recruiting, 26 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Regional West Medical Center Cancer Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Regional West Medical Center Cancer Center, 1 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".